Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo

Author:

Qian Xijing1,Wu Bingan1,Tang Hailin1,Luo Zhenghan1,Xu Zhenghao1,Ouyang Songying2,Li Xiangliang2,Xie Jianfeng3,Yi Zhigang4ORCID,Leng Qibin5,Liu Yan1,Qi Zhongtian1,Zhao Ping1ORCID

Affiliation:

1. Department of Microbiology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People’s Republic of China

2. Key Laboratory of Innate Immune Biology of Fujian Province, College of Life Sciences, Fujian Normal University, Fujian, People’s Republic of China

3. Fujian Provincial Center for Disease Control and Prevention, Fujian, People’s Republic of China

4. Key Laboratory of Medical Molecular Virology and Department of Medical Microbiology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China

5. State Key Laboratory of Respiratory Diseases, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, People’s Republic of China

Funder

National Natural Science Foundation of China

National Key R&D Program of China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3